MOUNTAIN VIEW, Calif., July 10, 2018 – Namocell Inc., a leading provider of high-performance single cell dispensing and sorting platforms for life science applications, today announced it has entered into a distribution agreement with MDxK Co., Ltd., one of the largest instrument providers for high quality molecular research and diagnostics in Korea, to distribute Namocell’s Namo Single Cell Dispenser in the Korean market.
“Korea’s biotech industry has been growing rapidly in recent years. We are excited to bring our affordable Namo Single Cell Dispenser to customers in Korea. Our Namo can dispense single cells into a 96-well plate in less than a minute and a 384-well plate in less than 3 minutes. Among several unique advantages over traditional cell sorters, the Namo’s low sorting pressure preserves cell viability, and proprietary cell cartridge enables sterile sortingand eliminates the system clogging issue typically seen with traditional sorters.” said Namocell CEO Dr. Junyu Lin. “MDxK has a long history of delivering leading innovative technology and outstanding customer services in Korea. We look forward to partnering with MDxK in serving customers in Korea.”
“We are very happy to be working with Namocell to bring their industry-leading single cell dispensing and sorting instruments to the Korean market,” said SungBo Shim, MDxK’s CEO. “The market has been waiting for a high-performance single cell dispensing and sorting instrument that is user-friendly and cost-effective. We believe the Namo Single Cell Dispenser is the perfect fit for the rapidly growing applications such as cell line development and single cell genomics in Korea.”
NamocellInc. provides the fastest way to a single cell. We are a leading provider of single cell dispensing and sorting technology based in the Silicon Valley. Our proprietary microfluidic-based single cell platforms simplify and empower a wide range of life science research and clinical applications, such as cancer immunotherapy, cell line development, rare cell isolation, CRISPR, single cell genomics, and monoclonal antibody isolation.
Molecular Diagnostics Korea (MDxK) Inc. is a leading provider of biotech instruments, consumables and services for high quality molecular research and diagnostics in Korea. The company is committed to providing innovative and cutting-edge technologies and solutions that will revolutionize life science research. MDxK was established in 2007 and is based in Seoul, Korea.
Tel: (650) 386-6878